Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model.

Stallons TAR, Saidi A, Tworowska I, Delpassand ES, Torgue JJ.

Mol Cancer Ther. 2019 May;18(5):1012-1021. doi: 10.1158/1535-7163.MCT-18-1103. Epub 2019 Mar 29.

PMID:
30926632
2.

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.

Meredith RF, Torgue JJ, Rozgaja TA, Banaga EP, Bunch PW, Alvarez RD, Straughn JM Jr, Dobelbower MC, Lowy AM.

Am J Clin Oncol. 2018 Jul;41(7):716-721. doi: 10.1097/COC.0000000000000353.

3.

Bacterial origin recognition complexes direct assembly of higher-order DnaA oligomeric structures.

Miller DT, Grimwade JE, Betteridge T, Rozgaja T, Torgue JJ, Leonard AC.

Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18479-84. doi: 10.1073/pnas.0909472106. Epub 2009 Oct 15.

4.

Mutational analysis reveals Escherichia coli oriC interacts with both DnaA-ATP and DnaA-ADP during pre-RC assembly.

Grimwade JE, Torgue JJ, McGarry KC, Rozgaja T, Enloe ST, Leonard AC.

Mol Microbiol. 2007 Oct;66(2):428-39. Epub 2007 Sep 10.

5.

SeqA blocking of DnaA-oriC interactions ensures staged assembly of the E. coli pre-RC.

Nievera C, Torgue JJ, Grimwade JE, Leonard AC.

Mol Cell. 2006 Nov 17;24(4):581-92.

Supplemental Content

Loading ...
Support Center